Opinion|Videos|March 21, 2025
Megan’s Journey With HER2+ Upper GI Cancer
Experts discuss Megan’s journey with HER2+ upper gastrointestinal (GI) cancer, highlighting key treatment strategies and challenges.
Advertisement
Episodes in this series
Advertisement
Related to this article
In the phase 2 EVITA trial, vitamin C did not slow clonal growth but was linked to fewer serious adverse events and longer exploratory survival.
In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.
At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.
At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.
At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.
ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Metastatic Breast Cancer: An NP and a Nurse-Patient on Hope and Honesty
2
Understanding Opdivo Qvantig® (nivolumab and hyaluronidase-nvhy): A Cancer Treatment with A Faster Delivery*
3
Breast Cancer Awareness: An APN on Personalized Care and Survivorship
4
Oral Vitamin C Misses Primary End Point in CCUS but Shows Survival Signal
5